Landfar Bio-medicine faces long-term revenue decline and pro...
Landfar Bio-medicine faces long-term revenue decline and profitability issues. Historical underperformance may urge caution among investors, despite possible buying opportunities.
Even After Rising 13% This Past Week, Landfar Bio-medicine (SZSE:000504) Shareholders Are Still Down 40% Over the Past Three Years
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4574Followers
0Following
9991Visitors
Follow